Neil Osterweil - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Neil Osterweil's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Neil Osterweil
Verified
Independent Medical Journalist, Freelance
Holliston
Beats
Biography
Neil Osterweil is an award-winning freelance writer with more than 40 years of experience covering medicine and science. He specializes in translating arcane technical subjects into feature articles and other materials for audiences with widely varying degrees of medical and scientific knowledge. His professional achievements include: Society of Professional Journalists Sigma Delta Chi Award, 2004 Society of Professional Journalists Green Eyeshade Award, 2001 Frances Larsen Award for Excellence in Medical Article Writing, 1999 Winner, Medical/Science Writing division, Write Stuff National Competition, 1986
pulmonary disease clinical research, Cardiology, Hematology-Oncology, rheumatology, Neurology , Gastroenterology, radiology, psychiatry, infectious diseases nephrology
kids, babies, infant travel, family travel
Content
By Neil Osterweil Verified| Oncology News Central Verified The theme for the 2025 American Association for Cancer Research (AACR) Annual Meeting, to be held at the McCormick Place Convention Center in Chicago April 25–30, is “Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact.”Program Committee Chairs Lillian L
By Neil Osterweil Verified| Substack@ Imagine if your car could fix itself while you’re driving it—sealing oil leaks, tightening drive belts, re-inflating tires—all occurring as you zip along at highway speeds, oblivious to the continuous repair process. DNA does just that for human cells, activating nearly 550 genes that produce proteins to zoom in and repair anywhere from around 10,000 to 1,000,000 molecular lesions (think of them as DNA bruises) that occur in
By Neil Osterweil Verified| Oncology News Central Verified For patients with unresectable EGFR-mutated non-small cell lung cancer (NSCLC) who do not have disease progression after definitive chemoradiotherapy (CRT), maintenance therapy with osimertinib (Tagrisso) significantly delays the time to first subsequent therapy and shows favorable but not statistically significant survival trends, according to an updated analysis from the LAURA trial. Suresh S
Company Info
Freelance
Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.
De Pere, Wisconsin, United States